PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- At ATTD 2022 - Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in ...

PARIS, Nov. 16, 2020 /PRNewswire/ -- The French company Diabeloop, a pioneer in therapeutic AI, and Terumo Corporation, a global leader in medical technology, announced today that they have signed an ...

Diabeloop announced today it has received the CE marking for the DBLG1™, its innovative technological solution to radically improve quality of life for T1D patients through better blood sugar ...

AID system based on DBLG1 and MEDISAFE WITH, Patient wearing MEDISAFE WITH TOKYO & PARIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Terumo Corporation, a global leader in medical technology, and the French ...

EASD 2022 – Diabeloop, a leader in therapeutic AI applied to insulin delivery, reports today on 12 months of use of its hybrid closed-loop DBLG1 System on a large, multi-country patient cohort. While ...

Frans Cromme, Chief Executive Officer of ViCentra, said: "We aim to deliver the best user experience as well as excellent clinical results with our Kaleido insulin pump and our partners. Kaleido with ...

PARIS , June 2, 2021 /PRNewswire/ -- DBLG1: easy to set up, simple to use, designed for every profile of T1D Relieving people with Type 1 diabetes from their heavy mental burden begins at the early ...

In the world of emerging automated insulin delivery systems for diabetes, French company Diabeloop stands out for its design work. This is because the company works on their designs with input from ...

Abrar's interests include phones, streaming, autonomous vehicles, internet trends, entertainment, pop culture and digital accessibility. In addition to her current role, she's worked for CNET's video, ...

Diabeloop announced today that it has obtained CE marking for its innovative and adjustable technological solution: DBL-hu. DBL-hu improves glycemic control and satisfaction for people living with a ...